← Hippo Holdings Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Short-term investments, at fair value (amortized cost: $152.5 and $167.6) | — | — | — | $187.1m | $167.6m | $152.5m | |
| Cash and cash equivalents | $452.3m | $775.6m | $194.5m | $142.1m | $197.6m | $218.3m | |
| Accounts receivable, net of allowance of $0.2 and $0.6 | $37.1m | $56.5m | $107.2m | $145.2m | $167.0m | $250.1m | |
| Prepaid reinsurance premiums | $129.4m | $231.6m | $309.9m | $335.6m | $274.2m | $353.7m | |
| Ceding commissions receivable | $21.3m | $41.6m | $45.8m | $73.8m | $79.5m | $98.7m | |
| Capitalized internal use software | $14.7m | $25.9m | $38.8m | $48.4m | $48.1m | $43.0m | |
| Intangible assets | $33.9m | $32.2m | $26.9m | $27.3m | $17.0m | $13.8m | |
| Other assets | $12.7m | $51.8m | $63.6m | $69.2m | $66.2m | $103.6m | |
| Fixed maturities available-for-sale, at fair value (amortized cost: $291.7 and $208.3) | $56.0m | $54.9m | $121.1m | $161.7m | $205.7m | $293.4m | |
| Restricted cash | $40.1m | $43.1m | $50.0m | $53.0m | $35.2m | $31.8m | |
| Reinsurance recoverable on paid and unpaid losses and loss adjustment expenses | $134.1m | $266.9m | $286.3m | $281.3m | $285.3m | $346.6m | |
| Losses and loss adjustment expense reserve | $105.1m | $260.8m | $293.8m | $322.5m | $350.0m | $420.4m | |
| Unearned premiums | $150.3m | $253.1m | $341.3m | $419.2m | $457.9m | $579.7m | |
| Reinsurance premiums payable | $86.1m | $159.4m | $207.1m | $260.1m | $248.6m | $304.4m | |
| Provision for commission | $28.2m | $12.3m | $5.0m | $24.7m | $34.3m | $36.3m | |
| Surplus note | — | — | — | — | $0 | $47.9m | |
| Total investments | $56.0m | $64.0m | $445.9m | $348.8m | $373.3m | $445.9m | |
| Total Hippo stockholders’ equity | ($199.6m) | $859.6m | $589.9m | $377.9m | $362.1m | $436.1m | |
| Total stockholders’ equity | ($199.5m) | $861.7m | $593.5m | $384.7m | $365.2m | $436.1m | |
| Total assets | $979.4m | $1.6b | $1.6b | $1.5b | $1.5b | $1.9b | |
| Total liabilities and stockholders’ equity | $979.4m | $1.6b | $1.6b | $1.5b | $1.5b | $1.9b | |
| Accrued expenses and other liabilities | $43.2m | $83.8m | $128.2m | $113.5m | $87.4m | $80.7m | |
| Total liabilities | $834.1m | $781.0m | $975.4m | $1.1b | $1.2b | $1.5b | |
| Common stock, $0.0001 par value; 80,000,000 shares authorized as of both December 31, 2025 and 2024; 25,699,704 and 24,866,803 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 0 | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | $56.9m | $1.5b | $1.6b | $1.6b | $1.6b | $1.7b | |
| Accumulated other comprehensive income (loss) | $100k | ($700k) | ($7.0m) | ($2.9m) | ($2.7m) | $1.8m | |
| Accumulated deficit | ($256.6m) | ($628.0m) | ($961.1m) | ($1.2b) | ($1.3b) | ($1.2b) | |
| Common stock, shares outstanding (in shares) | — | — | — | — | 24.9m | 25.7m | |
| Common stock, shares issued (in shares) | — | — | — | — | $24.9m | $25.7m | |
| Noncontrolling interest | $100k | $2.1m | $3.6m | $6.8m | $3.1m | $0 |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.